Risk factors for asthma among children in Maputo (Mozambique)

S Mavale-Manuel1, F Alexandre, N Duarte

  • 1Department of Pediatrics, Maputo Central Hospital, Maputo, Mozambique.

Allergy
|March 10, 2004
PubMed

Insights

Childhood asthma in Maputo is linked to family history of asthma and allergies, urban living, parental smoking, and early weaning. These factors are crucial for managing pediatric asthma effectively.

Area of Science:

  • Pediatric Pulmonology
  • Epidemiology
  • Environmental Health

Background:

  • Limited research exists on childhood asthma risk factors in African populations.
  • This study investigated key risk factors for pediatric asthma in Maputo, Mozambique.

Purpose of the Study:

  • To identify and analyze risk factors associated with childhood asthma in Maputo.
  • To provide data for improved asthma management strategies in the region.

Main Methods:

  • A case-control study involving 199 children (100 asthmatic, 99 non-asthmatic) aged 18 months to 8 years.
  • Data collected included family history of atopy, birth weight, environment, breastfeeding practices, and parental smoking.
  • Statistical analysis using odds ratios (OR) and confidence intervals (CI) to determine risk factor significance.

Main Results:

  • Asthmatic children were hospitalized more frequently (P < 0.0001).
  • Significant risk factors included urban residence (OR = 6.73), parental history of asthma (OR = 26.8) or rhinitis (OR = 4), parental smoking, and early weaning (OR = 2.4).

Conclusions:

  • Childhood asthma in Maputo is strongly associated with genetic predisposition (family history of asthma/rhinitis) and environmental factors.
  • Urban living, parental smoking, and early cessation of breastfeeding are significant contributors to pediatric asthma development.
  • Findings underscore the necessity of re-evaluating current management approaches for childhood asthma in Maputo.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: